Abstract
Human papillomavirus (HPV)-associated malignancies, mainly cervical cancer, are a global public health problem, especially in developing regions such as Latin America. Currently, the main treatments for advanced cervical cancer are radiotherapy combined with cisplatin-based chemotherapy. However, there is a high rate of relapse caused by the resistance developed by tumor cells. One of the…